期刊文献+

达英-35与二甲双胍联用对PCOS患者激素水平及卵巢状态的影响 被引量:5

The Effect of Hormone Levels and Ovarian Situation with the Treatment of ECAT and Metformin in PCOS
在线阅读 下载PDF
导出
摘要 目的研究达英-35与二甲双胍对多囊卵巢综合征(PCOS)患者激素水平及卵巢状态的影响。方法选择PCOS患者90例,随机分为对照、达英-35和联用三组。达英-35组接受达英-35单独治疗,联用组接受二甲双胍及达英-35治疗,连续3个月,治疗前后分别测定黄体生成素(LH)、促卵泡素(FSH)、雌二醇(E2)、睾酮(T)。测量每侧卵巢内卵泡数目、卵巢体积。结果经治疗3个周期后,达英-35组的E2、LH、LH/FSH和T均显著低于对照组(P<0.05),但FSH下降不明显(P>0.05);而联用组E2、LH、FSH、LH/FSH和T均较对照组显著改善(P<0.05);联用组与达英-35组比较,仅FSH间的差异有统计学意义(P<0.05)。联用组双侧卵巢体积较治疗前明显缩小,卵泡数目也明显减少,与服药前相比均有显著性差异(P<0.01)。两治疗组未出现严重不良反应。结论二甲双胍与达英-35合并用于PCOS患者能改善PCOS患者内分泌水平,显著改善卵巢状态。 Objective To investigate the effect of hormone levels and ovarian situation with the treatment of ECAT and mefformin in PCOS. Methods Ninty patients with PCOS were divided into three groups:control,ECAT and united. The ECAT group was just treated with ECAT. The united group was treated with metformin besides ECAT. Their LH,FSH,E2,T,Bilateral ovarian volume and follicle numbers were measured after three months treatment. Results E2,LH,LH/FSH and T of the ECAT group were significant lower than that of the control group,but there was no significant difference of FSH between them. The hormone level of the united group was changed significantly,But there was no significant between the ECAT group and the united group except FSH. Bilateral ovarian volume and follicle numbers were changed significantly after treatment in the united group. Conclusion The hormone level and ovarian situation can be improved of the patients of PCOS by united treatment of ECAT and mefformin.
出处 《中国现代医生》 2009年第18期6-7,40,共3页 China Modern Doctor
关键词 达英-35 二甲双胍 多囊卵巢综合征 Ethinylestradiol and Cyproterone Acetate Tablets(ECAT) Metformin PCOS
  • 相关文献

参考文献7

二级参考文献53

  • 1李梅,李志凌,李红发.多囊卵巢综合征卵泡闭锁调节机制的研究进展[J].生殖医学杂志,2004,13(6):377-380. 被引量:14
  • 2甄秀梅,秦英慧,陈子江.多囊卵巢综合征的综合治疗新进展[J].国外医学(计划生育分册),2005,24(2):84-86. 被引量:13
  • 3Bahceci M, Tuzcu A, Bahceci S,et al. Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome[J]? J Endocrinol Invest, 2003,26(7) :655-659.
  • 4Dravecka I, Lazurova I, Kraus V. Obesity is major factor de terminning an insulin sensitivity and androgen production in women with anovulary cycles[J]. Bretisl Lek Listy, 2003,104(12) :393-399.
  • 5Wasko R, Komarowska H, Warenik-Szymankiewicz A, et al. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome[J]. Horm Metab Res, 2004, 36 (3): 170-173.
  • 6Amato G, Conte M, Mazziotti G,et al. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimula ted cycles[J]. Obstet Gynecol, 2003,101(6):1177-1182.
  • 7Cengiz C. The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligo menorrheic patients without PCOS[J]. Gynecol Endocrinol,2002,16(6): 447-452.
  • 8Hacihanefioglu B,Seyisoglu H,Karsidag K,et al. Influence of insulin resistence on total renin level in normotensive woman with polycystic ovary syndrome[J]. Fertil Steril, 2000,73 (2):261-265.
  • 9Minegishi T, Hirakawa T, Kishi H,et al. A role of insulin like growth factor 1 for follicle-stimulating hormone receptor expression in rat granulosa cells [J]. Biol Reprod, 2000, 62(2) :325-333.
  • 10Thierry van Dessel HJ, Lee PD, Faessen G,et al. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 1999,84 (9):3030-3035.

共引文献55

同被引文献44

引证文献5

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部